Prodrugs of Antiinfective Agents: A Review

Authors

  • Mona Piplani Institute of Pharmaceutical Sciences Kurukshetra University, Kurukshetra INDIA
  • Avtar Chand Rana Institute of Pharmaceutical Sciences Kurukshetra University, Kurukshetra INDIA
  • Prabodh Chander Sharma Institute of Pharmaceutical Sciences Kurukshetra University, Kurukshetra INDIA

DOI:

https://doi.org/10.18433/J3X61S

Abstract

Prodrugs are the pharmacologically inactive derivatives of active drugs typically intended to optimize the exposure of active drug at target site, through manipulation of its physicochemical, biopharmaceutical or pharmacokinetic properties. This approach has a number of advantages over conventional drug administration. Antiinfective agents are associated with number of limitations, responsible for their reduced bioavailability. Various antiinfective prodrugs have been synthesized with reduced side effects and improved pharmacological properties. The present paper illustrates different vistas of prodrug approach of antiinfective agents describing brief classification, synthetic approaches, pharmacological aspects and recent patents. It is a very productive area of research and its prologue in human therapy has given triumphant outcomes in improving the clinical and therapeutic effectiveness of drugs.

This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.

Downloads

Download data is not yet available.

Downloads

Published

2016-02-08

How to Cite

Piplani, M., Rana, A. C., & Sharma, P. C. (2016). Prodrugs of Antiinfective Agents: A Review. Journal of Pharmacy & Pharmaceutical Sciences, 19(1), 82–113. https://doi.org/10.18433/J3X61S

Issue

Vol. 19 No. 1 (2016)

Section

Review Articles

License

This is an open access journal with free of charge non-commercial download. At the time of submission, authors will be asked to transfer the copyright to the accepted article to the Journal of Pharmacy and Pharmaceutical Sciences. The author may purchase the copyright for $500 upon which he/she will have the exclusive copyright to the article. Nevertheless, acceptance of a manuscript for publication in the Journal is with the authors' approval of the terms and conditions of the Creative Commons copyright license Creative Common license (Attribution-ShareAlike) License for non-commercial uses.

CLOCKSS system has permission to collect, preserve, and serve this Archival Unit.